72 related articles for article (PubMed ID: 36805885)
1. Hepatitis C virus and lymphoma.
Viswanatha DS; Dogan A
J Clin Pathol; 2007 Dec; 60(12):1378-83. PubMed ID: 18042694
[TBL] [Abstract][Full Text] [Related]
2. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.
Arcaini L; Vallisa D; Rattotti S; Ferretti VV; Ferreri AJM; Bernuzzi P; Merli M; Varettoni M; Chiappella A; Ambrosetti A; Tucci A; Rusconi C; Visco C; Spina M; Cabras G; Luminari S; Tucci M; Musto P; Ladetto M; Merli F; Stelitano C; d'Arco A; Rigacci L; Levis A; Rossi D; Spedini P; Mancuso S; Marino D; Bruno R; Baldini L; Pulsoni A
Ann Oncol; 2014 Jul; 25(7):1404-1410. PubMed ID: 24799461
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis.
Forghieri F; Luppi M; Barozzi P; Maffei R; Potenza L; Narni F; Marasca R
Clin Dev Immunol; 2012; 2012():807351. PubMed ID: 22844326
[TBL] [Abstract][Full Text] [Related]
4. Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.
Mazzaro C; Visentini M; Gragnani L; Vit F; Tissino E; Pozzo F; Papotti R; Casato M; Zignego AL; Bittolo T; Zucchetto A; Degan M; Bomben R; Gattei V
Br J Haematol; 2023 Oct; 203(2):237-243. PubMed ID: 37491625
[TBL] [Abstract][Full Text] [Related]
5. Lessons of the month 2: Ocular manifestations and complications of hepatitis C infection.
Fang SL; Teo L; Loo CY; Li JW; Santosa A
Clin Med (Lond); 2021 Jul; 21(4):e417-e419. PubMed ID: 35192489
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C Epidemiology: Insights from a Comprehensive Cohort Study in ASST Melegnano and Martesana, Lombardia Region, Northern Italy.
Nardone M; Di Stasio D; Lucchese A; Gentili D; Cattabianchi G; Signorelli C; Sarchi P; Pulcrano G; Lembo V; Pirola PM; Lauritano D; Carinci F
Pathogens; 2024 Feb; 13(3):. PubMed ID: 38535558
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapy.
Mazzaro C; Dal Maso L; Visentini M; Ermacora A; Andreone P; Gattei V; Pozzato G
Hematol Oncol; 2021 Oct; 39(4):439-447. PubMed ID: 34477233
[TBL] [Abstract][Full Text] [Related]
8. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M; Carli G; Arcaini L; Visco C
World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Pozzato G; Mazzaro C; Gattei V
Minerva Med; 2021 Apr; 112(2):215-227. PubMed ID: 33263375
[TBL] [Abstract][Full Text] [Related]
10. HCV-associated lymphomas.
Fiorilli M; Mecucci C; Farci P; Casato M
Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus-related cryoglobulinemic vasculitis.
Mazzaro C; Mauro E; Ermacora A; Doretto P; Fumagalli S; Tonizzo M; Toffolutti F; Gattei V
Minerva Med; 2021 Apr; 112(2):175-187. PubMed ID: 33198444
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]